71 results on '"Ibragimova, M. K."'
Search Results
2. Human papillomavirus and lung cancer: an overview and a meta-analysis
3. HPV-associated cervical cancer: Current status and prospects
4. Combined modality treatment of patients with stage IV gastric cancer with peritoneal carcinomatosis
5. GENOME-WIDE ANALYSIS OF A TRIPLE NEGATIVE BREAST TUMORS
6. MECHANISMS OF ESCAPE FROM REPLICATIVE SENESCENCE OF TUMOUR CELLS AFTER EXPOSURE TO CHEMOTHERAPY
7. PREDICTIVE AND PROGNOSTIC SIGNIFICANCE OF PALB2 GENE MUTATIONS IN BREAST TUMORS
8. Optimization of mammosphere formation assay for quantif cation of il6-induced stemness in differentiated breast cancer cells
9. Expression heterogeneity of ABC-transporter family genes and chemosensitivity genes in gastric tumor, carcinomatosis and lymph node metastases
10. Prognostic and Predictive Significance of mRNA Expression of ABC-transporter Genes in Patients with Non-small Cell Lung Cancer
11. Natural and chemotherapy-induced clonal evolution of tumors
12. Predictive and prognostic significance of loss of heterozygosity in ABC transporter genes in breast cancer
13. Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy
14. Gastric cancer: modern approaches and prospects of treatment for peritoneal carcinomatosis (literature review)
15. STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER
16. Aberrations of the number of copies (CNA) in the genome of luminal B breast tumor
17. Gene expression analysis of ABC transporter family in breast tumors: relationship with chemotherapy effect and disease prognosis
18. ASSOCIATION OF THE COMBINATION OF STEMNESS GENE AMPLIFICATIONS AND COPY NUMBER ABERRATIONS OF WNT-SIGNALING GENES IN BREAST TUMORS WITH METASTASIS
19. LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
20. PARP1 inhibitors in breast cancer therapy. Mechanism of action and clinical use
21. Assessing survival rate of HPV-positive and HPV-negative cervical cancer patients
22. IN VITRO MODELING OF TUMOR INTERCLONAL INTERACTIONS USING BREAST CANCER CELL LINES.
23. The prognostic significance of BRCA1 gene expression in patients with breast cancer
24. Human papillomavirus in head and neck cancer (literature review)
25. RESPONSE TO NEOADYAVANT CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN BREAST CANCER PATIENTS WITH BRCA1 DELETION IN TUMOR
26. mRNA expression of chemosensitivity genes as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer
27. EPIDEMIOLOGY ASPECTS OF HUMAN PAPILLOMAVIRUS INFECTION OF LUNG CANCER: A REVIEW
28. Physical status of human papillomavirus in the prognosis of recurrence of low-grade and-high-grade cervical intraepithelial lesions
29. BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer
30. The clinical observation of human papillomavirus positive breast tumor
31. GENOME-WIDE ASSOCIATION STUDY OF LOSS OF HETEROZYGOSITY AND METASTASIS-FREE SURVIVAL IN BREAST CANCER PATIENTS
32. Copy number aberrations landscape of a breast tumor, connection with the efficiency of neoadjuvant chemotherapy
33. Expression of the BRCA1 gene in a breast tumor: Correlation with the effect of neoadjuvant chemotherapy
34. Phenomenon of loss of heterozygosity in tumour tissue of breast cancer: association with expression of monoresistance genes
35. EXPRESSION of MACROPHAGe-ASSOCIATED GENES IN BREAST TUMORS: RELATION TO TUMOR PROGRESSION
36. Integrative and episomal forms of genotype 16 of human papillomavirus in patients with cervical intraepithelial neoplasia and cervical cancer
37. COMPREHENSIVE META-ANALYTICAL SUMMARY ON HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCER
38. PROGNOSTIC SIGNIFICANCE OF Ki67, CYCLOOXYGENASE-2 (COX-2) AND p16ink4a IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
39. Microarray study of single nucleotide polymorphisms and expression of ATP-binding cassette genes in breast tumors
40. Disease-free and overall survival of patients diagnosed with HPV-associated or HPV-negative cervical cancer
41. Prognostic significance of ERCC1, RRM1, TOP1, TOP2A, TYMS, TUBB3, GSTP1 and BRCA1 mRNA expressions in patients with non-small-cell lung cancer receiving a platinum-based chemotherapy
42. Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy
43. Prognostic significance of monoresistance gene expression in the tumors of patients with small cell lung cancer after preoperative chemotherapy
44. 1935PSomatic-stem transition of tumor cells is a key link in the metastasis.
45. CNA Landscape of HER2-Negative Breast Cancer in Anthracycline-Based Neoadjuvant Chemotherapy Regimens.
46. MALAT1 Long Non-coding RNA and Its Role in Breast Carcinogenesis.
47. Human papillomavirus and ovarian cancer (review of literature and meta-analysis).
48. NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer.
49. Changes in the genetic landscape during the malignization of high grade squamous intraepithelial lesion into cervical cancer.
50. [Viral co-infection with head and neck tumors].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.